Pricing Log in Create free account
Saturday 17 October 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

299.77 6.47 −2.11%
Market cap
$14.6B
P/E
0.0×
Fwd P/E
29.6×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Charles River Laboratories International, Inc. (CRL) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Charles River Laboratories International, Inc. (CRL) trades at a P/S ratio of 3.6×. Over the past ten years it has ranged from 1.3× (April 2025) to 7.0× (September 2021); the current reading is higher than 85% of that period. That is below the Diagnostics & Research industry median of 4.4× and in line with the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.5× 5.14%
FY2024 2.3× (19.41%)
FY2023 2.9× 4.12%
FY2022 2.8× (47.86%)
FY2021 5.4× 26.42%
FY2020 4.2× 49.10%
FY2019 2.8× 18.59%
FY2018 2.4× (15.33%)
FY2017 2.8× 32.18%
FY2016 2.1× (21.95%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 2.7× 29.88%
Mar 2026 2.1× (14.84%)
Dec 2025 2.5× 28.67%
Sep 2025 1.9× 3.38%
42 more quarters

Against its own ten years

Low 1.3× High 7.0×
Ten-year median 2.7×
Current reading's percentile 84

P/S ratio against peers

Company P/S ratio
ICLR ICON PLC compare 1.6×
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated compare 2.3×
CRL Charles River Laboratories International, Inc. 3.6×
QGEN QIAGEN N.V. compare 4.5×
RVTY Revvity Inc. compare 5.8×
MEDP Medpace Holdings, Inc. compare 6.3×
GH Guardant Health, Inc. compare 17.8×
TWST Twist Bioscience Corporation compare 19.2×
Diagnostics & Research industry median 4.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on CRL